Literature DB >> 16131042

Myeloma bone disease: pathogenesis and treatment.

G David Roodman1.   

Abstract

Treatment regimens for multiple myeloma are evolving because of new advances in both pharmacotherapy and transplantation strategies. The Multiple Myeloma Research Foundation (MMRF) has gathered the top thought leaders in myeloma research to prepare an engaging, interactive series of case studies in multiple myeloma, which are available online at www.multiplemyeloma.org and are published on a regular basis in ONCOLOGY. For more information about the interactive series, see the MMRF ad on page 1089.

Entities:  

Mesh：

Year:  2005        PMID： 16131042

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


  7 in total

1.  Tumor cell p38 MAPK: A trigger of cancer bone osteolysis.

Authors:  Huan Liu; Jin He; Jing Yang
Journal:  Cancer Cell Microenviron       Date:  2015-01-01

2.  Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.

Authors:  Kah-Whye Peng; Ahmet Dogan; Julie Vrana; Chunsheng Liu; Hooi T Ong; Shaji Kumar; Angela Dispenzieri; Allan B Dietz; Stephen J Russell
Journal:  Am J Hematol       Date:  2009-07       Impact factor: 10.047

3.  Vitamin D deficiency in a man with multiple myeloma.

Authors:  Zackariah Clement; Meeghan Ashford; Seeva Sivakumaran
Journal:  N Am J Med Sci       Date:  2011-10

4.  Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma.

Authors:  J Yang; J He; J Wang; Y Cao; J Ling; J Qian; Y Lu; H Li; Y Zheng; Y Lan; S Hong; J Matthews; M W Starbuck; N M Navone; R Z Orlowski; P Lin; L W Kwak; Q Yi
Journal:  Leukemia       Date:  2012-03-19       Impact factor: 11.528

5.  GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival.

Authors:  Daniela N Petrusca; Patrick L Mulcrone; David A Macar; Ryan T Bishop; Evgeny Berdyshev; Attaya Suvannasankha; Judith L Anderson; Quanhong Sun; Philip E Auron; Deborah L Galson; G David Roodman
Journal:  Cancers (Basel)       Date:  2022-02-02       Impact factor: 6.639

6.  Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma.

Authors:  Maria E S Takahashi; Camila Mosci; Edna M Souza; Sérgio Q Brunetto; Cármino de Souza; Fernando V Pericole; Irene Lorand-Metze; Celso D Ramos
Journal:  Nucl Med Commun       Date:  2020-04       Impact factor: 1.698

7.  Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis.

Authors:  Daniela N Petrusca; Denise Toscani; Feng-Ming Wang; Cheolkyu Park; Colin D Crean; Judith L Anderson; Silvia Marino; Khalid S Mohammad; Dan Zhou; Rebecca Silbermann; Quanhong Sun; Noriyoshi Kurihara; Deborah L Galson; Nicola Giuliani; G David Roodman
Journal:  J Hematol Oncol       Date:  2018-10-04       Impact factor: 17.388
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.